Immix Biopharma, Inc. (IMMX) stock
Close on Nov 13, 2026Market cap $560.87MP/E –Yield –
Immix Biopharma statistics
63 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.67
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 92.7%
- 10.8%
- Shares Change (QoQ)
- 17.2%
- 0.50%
- Float
- 59M
- 49M
- Shares Held by Insiders
- 17.0%
- 11.7%
- Shares Held by Institutions
- 78.6%
- 56.4%
Short sellingIndustry
- Short Interest
- 11M
- –
- Short Interest Change
- 5.07%
- -0.80%
- Short % of Float
- 19.0%
- 9.01%
- Short % of Shares Outstanding
- 15.7%
- 6.30%
- Days to Cover
- 9.24
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $15.10
- –
- 52-Week Low
- $3.45
- –
- 20-Day Moving Average
- $8.09
- –
- 50-Day Moving Average
- $9.82
- –
- 200-Day Moving Average
- $9.62
- –
- Average True Range (14)
- $0.66
- –
- Price Change (1 Week)
- -2.73%
- -1.15%
- Price Change (1 Month)
- -9.68%
- -4.87%
- Price Change (3 Months)
- -30.9%
- -21.0%
- Price Change (6 Months)
- -21.1%
- -20.6%
- Price Change (YTD)
- 49.9%
- -23.6%
- Price Change (1 Year)
- 110.8%
- -22.4%
- Price Change (3 Years)
- 78.2%
- -29.5%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.67
- 0.70
- Relative Strength Index (14)
- 42.5
- 43.4
- Volatility (1 Year)
- 83.3%
- 80.1%
- Beta (5 Years)
- 0.96
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -26.9%
- -49.9%
- Return on Assets (ROA)
- -25.3%
- -40.6%
- Return on Capital Employed (ROCE)
- -14.9%
- -37.9%
Financial positionIndustry
- Current Ratio
- 33.72
- 3.30
- Quick Ratio
- 33.55
- 2.39
EfficiencyIndustry
- Profits Per Employee
- -$2.20M
- -$689.41K
- Employee Count
- 21
- 74
- WACC
- 9.88%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$46.23M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $336.30M
- $17.76M
- Net Cash Per Share
- $4.70
- $0.80
- Equity (Book Value)
- $335.06M
- $53.89M
- Book Value Per Share
- $4.68
- $1.50
- Tangible Book Value
- $335.06M
- $27.13M
- Working Capital
- $328.05M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$339.90K
- -$1.00M
- FCF Per Share
- -$0.63
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -8.24%
- -21.8%
- FCF Yield
- -8.07%
- -9.44%
Scores and fair valueIndustry
- Altman Z-Score
- 30.99
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | IMMX | S&P 500 | Difference | IMMX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -9.8% | -3.0% | −6.7 pts | ||
| 3 months | -28.2% | -2.8% | −25.4 pts | ||
| Year to date | +49.9% | +11.5% | +38.4 pts | ||
| 1 year | +117.2% | +13.5% | +103.7 pts | ||
| 3 years | +84.5% | +77.7% | +6.8 pts | +22.6% | +21.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
11M IMMX shares were sold short on Oct 30, 2026, up 5.1% from the previous report, or 18.96% of the shares available to trade. At recent volumes it would take 9.2 days to buy them back. Over the last 20 sessions, 56.2% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 11,254,167 | +5.1% | 1,217,550 | 9.2 |
| Oct 15, 2026 | 10,710,976 | +3.1% | 1,428,643 | 7.5 |
| Sep 30, 2026 | 10,390,288 | +8.0% | 2,032,334 | 5.1 |
| Sep 15, 2026 | 9,621,660 | +0.0% | 1,241,307 | 7.8 |
| Aug 31, 2026 | 9,616,997 | -7.2% | 1,636,228 | 5.9 |
| Aug 14, 2026 | 10,357,703 | +9.1% | 1,487,368 | 7.0 |
| Jul 31, 2026 | 9,492,705 | +11.7% | 1,820,249 | 5.2 |
| Jul 15, 2026 | 8,501,228 | +7.9% | 1,836,693 | 4.6 |
| Jun 30, 2026 | 7,881,944 | +98.6% | 2,933,999 | 2.7 |
| Jun 15, 2026 | 3,968,428 | -1.6% | 1,148,041 | 3.5 |
| May 29, 2026 | 4,033,450 | +25.3% | 1,989,125 | 2.0 |
| May 15, 2026 | 3,219,433 | +6.6% | 769,852 | 4.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?